Stock Region Watchlist
Stock Region Watchlist Newsletter - Watchlist for Tuesday, December 31, 2024
Stock Region Watchlist Newsletter - Watchlist For Tuesday, December 31, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Welcome to this edition of Stock Region's watchlist! Today, we’re spotlighting three stocks with noteworthy trends and developments. Before we jump in, here’s a quick disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Always conduct your own research or consult with a licensed financial advisor before making any investment decisions.
1. MicroStrategy ($MSTR)
Recent News:
MicroStrategy's stock has faced significant volatility, with its price now under $300. This marks a sharp 46% decrease from its November highs. The decline stems from growing concerns about the company's Bitcoin-heavy strategy and its methods of securing funding.
Reason to Watch:
MicroStrategy’s deep ties to Bitcoin make it a crucial stock for anyone keeping an eye on cryptocurrency. Volatility-driven opportunities could attract both short-term traders and long-term investors. For the short term, keep an eye on levels above $317.75 for potential upside momentum and a downside break below $302.96 for further correction risks.
2. VeriSign ($VRSN)
Recent News:
VeriSign has been climbing steadily, recently trading at $205.10. Strong quarterly performance includes a 4.1% revenue increase year-over-year, a 7.1% boost in operating income, and an impressive 12.3% rise in earnings per share. Additionally, its appeal has been bolstered by the interest of high-profile investors such as Warren Buffett.
Reason to Watch:
With solid financial gains and proven interest from market heavyweights, VeriSign has positioned itself as a growth prospect. Watch for upward movement beyond $211.43 to confirm further bullish action, while a dip below $205.10 might signal near-term caution.
3. Sangamo Therapeutics ($SGMO)
Recent News:
Sangamo took a major hit, dropping nearly 50% after Pfizer decided to end their collaboration on the development of a gene therapy for hemophilia A.
Reason to Watch:
While this development hits hard, there could be a silver lining. Sangamo’s opportunity to regain the full rights to its promising hemophilia A program could pave the way for recovery or strategic shifts. Investors may consider levels above $1.18 for signs of rebound potential, while a dip below $1.04 could indicate more turbulence ahead.
Thank you for being a part of Stock Region's community. We hope this watchlist helps guide your investment research as you close out the year. Don’t forget to stay informed and make decisions that align with your strategy and risk tolerance.
Happy New Year,
The Stock Region Team
Final disclaimer: All opinions expressed in this newsletter are purely educational and informational. Stock Region does not guarantee performance and is not liable for any losses incurred. Always consult with a professional before trading or investing.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net